MAM
BBP icon

Mystic Asset Management’s Virtus Biotech ETF BBP Stock Holding History

Mystic Asset Management’s Portfolio BBP Stock Details BBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-25
Closed -$1K – 173
2021
Q4 		$1K Buy
+25
New +$1.24K ﹤0.01% 415

Other funds holding BBP

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
FAIM
Financial Advocates Investment Management Olympia, Washington $178M AUM 21.03% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return
MCC
Money Concepts Capital Palm Beach Gardens, Florida $1.81B AUM 21.93% 1-Year Est. Return

Mystic Asset Management's BBP Position: Q1 2022 in Review

Mystic Asset Management sold out of Virtus Biotech ETF (BBP) in Q1 2022, closing a stake of 25 shares — an estimated $1K sold.

Mystic Asset Management first reported a position in BBP in Q4 2021 and held it in 1 quarter. The position peaked at $1K in Q4 2021. 11 funds tracked by Wall St. Rank hold BBP as of Q1 2022.

  • Mystic Asset Management reported no remaining Virtus Biotech ETF position as of Q1 2022 after selling out during the quarter.
  • Mystic Asset Management sold 25 Virtus Biotech ETF shares in Q1 2022, an estimated $1K.
  • Mystic Asset Management first reported a position in Virtus Biotech ETF in Q4 2021 and held it in 1 quarter.
  • Mystic Asset Management's Virtus Biotech ETF position peaked at $1K in Q4 2021.
  • 11 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q1 2022.

Based on Mystic Asset Management's 13F filing for Q1 2022, filed 11 May 2022.